** CK Life Sciences 0775.HK soars as much as 41.7% to HK$0.68, highest since November 2023
** Stock on course for biggest one-day pct rise since June 2022; fourth biggest pct gainer on HK bourse
** Healthcare and pharma products maker files Original Grant Patent application in Hong Kong and provisional patent application with the U.S. Patent and Trademark Office for its circular mRNA and fusion protein TROP2 cancer vaccines
** Says successful commercialisation of TROP2 cancer vaccine could potentially generate significant economic benefits for co
** Stock up 17.1% YTD
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。